Karydas Daphne 4
4 · Mineralys Therapeutics, Inc. · Filed Sep 14, 2023
Insider Transaction Report
Form 4
Karydas Daphne
Director
Transactions
- Award
Stock Option
2023-09-13+44,000→ 44,000 totalExercise: $12.02Exp: 2033-09-13→ Common Stock (44,000 underlying)
Footnotes (1)
- [F1]The stock option vests in 36 monthly installments beginning on October 13, 2023.